Mutsaers SE - Search Results

1

How to Better Understand the Influence of Host Genetics on Developing an Effective Immune Response to Thoracic Cancers.

Behrouzfar K, Burton K, Mutsaers SE, Morahan G, Lake RA, Fisher SA. Behrouzfar K, et al. Among authors: mutsaers se. Front Oncol. 2021 Jun 21;11:679609. doi: 10.3389/fonc.2021.679609. eCollection 2021. Front Oncol. 2021. PMID: 34235080 Free PMC article. Review.

2

Spontaneously immortalized mouse mesothelial cells display characteristics of malignant transformation.

Sherwood AL, Mutsaers SE, Peeva VK, Robinson C, DeSilva CJ, Swanson NR, Lake RA. Sherwood AL, et al. Among authors: mutsaers se. Cell Prolif. 2008 Dec;41(6):894-908. doi: 10.1111/j.1365-2184.2008.00560.x. Cell Prolif. 2008. PMID: 19040568 Free PMC article.

3

Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance.

Cleaver AL, Bhamidipaty K, Wylie B, Connor T, Robinson C, Robinson BW, Mutsaers SE, Lake RA. Cleaver AL, et al. Among authors: mutsaers se. Carcinogenesis. 2014 Feb;35(2):407-14. doi: 10.1093/carcin/bgt322. Epub 2013 Oct 15. Carcinogenesis. 2014. PMID: 24130165

4

A Subset of Malignant Mesothelioma Tumors Retain Osteogenic Potential.

Lansley SM, Pedersen B, Robinson C, Searles RG, Sterrett G, van Bruggen I, Lake RA, Mutsaers SE, Prêle CM. Lansley SM, et al. Among authors: mutsaers se. Sci Rep. 2016 Nov 25;6:36349. doi: 10.1038/srep36349. Sci Rep. 2016. PMID: 27886205 Free PMC article.

5

Mesothelial cells in tissue repair and fibrosis.

Mutsaers SE, Birnie K, Lansley S, Herrick SE, Lim CB, Prêle CM. Mutsaers SE, et al. Front Pharmacol. 2015 Jun 9;6:113. doi: 10.3389/fphar.2015.00113. eCollection 2015. Front Pharmacol. 2015. PMID: 26106328 Free PMC article. Review.

6

Emerging role of immune cells as drivers of pulmonary fibrosis.

Mutsaers SE, Miles T, Prêle CM, Hoyne GF. Mutsaers SE, et al. Pharmacol Ther. 2023 Dec;252:108562. doi: 10.1016/j.pharmthera.2023.108562. Epub 2023 Nov 10. Pharmacol Ther. 2023. PMID: 37952904 Review.

7

Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma.

Birnie KA, Prêle CM, Thompson PJ, Badrian B, Mutsaers SE. Birnie KA, et al. Among authors: mutsaers se. Oncotarget. 2017 Aug 24;8(44):78193-78207. doi: 10.18632/oncotarget.20409. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100460 Free PMC article. Review.

8

Mesothelial cells regulate immune responses in health and disease: role for immunotherapy in malignant mesothelioma.

Mutsaers SE, Pixley FJ, Prêle CM, Hoyne GF. Mutsaers SE, et al. Curr Opin Immunol. 2020 Jun;64:88-109. doi: 10.1016/j.coi.2020.04.005. Epub 2020 May 30. Curr Opin Immunol. 2020. PMID: 32485577 Review.

9

Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models.

Lam SK, Mutsaers SE. Lam SK, et al. Among authors: mutsaers se. Front Pharmacol. 2022 Sep 6;13:1015959. doi: 10.3389/fphar.2022.1015959. eCollection 2022. Front Pharmacol. 2022. PMID: 36147341 Free PMC article. No abstract available.

10

Idiopathic pulmonary fibrosis and a role for autoimmunity.

Hoyne GF, Elliott H, Mutsaers SE, Prêle CM. Hoyne GF, et al. Among authors: mutsaers se. Immunol Cell Biol. 2017 Aug;95(7):577-583. doi: 10.1038/icb.2017.22. Epub 2017 Mar 30. Immunol Cell Biol. 2017. PMID: 28356570 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page